Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001662579-24-000070
Filing Date
2024-09-03
Accepted
2024-09-03 16:51:21
Documents
2
Period of Report
2024-08-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1725396676.html 3  
1 FORM 3 wk-form3_1725396676.xml 3 1623
2 EX-24 fawell.txt EX-24 4296
  Complete submission text file 0001662579-24-000070.txt   7407
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Issuer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C4 THERAPEUTICS, INC. 490 ARSENAL WAY, SUITE 120 WATERTOWN MA 02472
Business Address
Fawell Stephen (Reporting) CIK: 0002033387 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39567 | Film No.: 241274769